It is important that the change of approach to prophylactic treatment is supported by economic data and also that quantitative economic data are essential to back healthcare budget allocation applications to regional policy makers. In the absence of European economic data on UTIs, data from the US suggest a US$1.6 billion burden, the majority stemming from indirect costs (productivity losses totalling nearly US$1 billion) and the rest attributed to direct costs (healthcare services). The distress experienced by patients with recurrent UTIs has been estimated to be similar to that caused by more recognisable conditions that are also way better funded and supported, such as Alzheimer’s and dementia.
Urinary Tract Infections – An Economic Issue
TARRICONE, ROSANNA;CIANI, ORIANA
2012
Abstract
It is important that the change of approach to prophylactic treatment is supported by economic data and also that quantitative economic data are essential to back healthcare budget allocation applications to regional policy makers. In the absence of European economic data on UTIs, data from the US suggest a US$1.6 billion burden, the majority stemming from indirect costs (productivity losses totalling nearly US$1 billion) and the rest attributed to direct costs (healthcare services). The distress experienced by patients with recurrent UTIs has been estimated to be similar to that caused by more recognisable conditions that are also way better funded and supported, such as Alzheimer’s and dementia.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
